Inventor profile of:

MICHAEL MOLHOJ

City:

MUENCHEN

Country:

Germany

Published Applications:

27

Last publication date:

2026-01-22

Top Assignees for applications by MICHAEL MOLHOJ

The entities that hold a legal rights for patent applications filed by inventor MOLHOJ MICHAEL:

Recent patent applications by MOLHOJ MICHAEL

MICHAEL MOLHOJ from MUENCHEN, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-22
US20260022172A1
Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#2 | 2024-09-26
US20240317879A1
Chemistry; metallurgy

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

#3 | 2024-05-02
US20240141044A1
Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#4 | 2023-09-14
US20230287118A1
Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#5 | 2023-08-24
US20230265177A1
Chemistry; metallurgy

Humanized anti-Tau(PS422) antibodies and methods of use

#6 | 2022-12-22
US20220403027A1
Chemistry; metallurgy

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

#7 | 2022-09-29
US20220306761A1
Chemistry; metallurgy

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

#8 | 2021-10-07
US20210309730A1
Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

#9 | 2021-07-01
US20210199653A1
Physics

Direct affinity measurement of human IgG1 binding multimeric antigens

#10 | 2021-07-01
US20210198383A1
Chemistry; metallurgy

Method for determining the in vivo interaction mode

#11 | 2021-05-13
US20210139571A1
Chemistry; metallurgy

Humanized anti-Tau(pS422) antibodies and methods of use

#12 | 2020-07-23
US20200231673A1
Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#13 | 2020-04-02
US20200103413A1
Physics

Method for detecting multispecific antibody light chain mispairing

#14 | 2019-01-17
US20190018009A1
Physics

DIRECT AFFINITY MEASUREMENT OF HUMAN IGG1 BINDING MULTIMERIC ANTIGENS

#15 | 2019-01-17
US20190016827A1
Chemistry; metallurgy

METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE

#16 | 2018-08-09
US20180222981A1
Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#17 | 2018-08-09
US20180222980A1
Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#18 | 2018-03-22
US20180079804A1
Chemistry; metallurgy

Humanized anti-tau(pS422) antibodies and methods of use

#19 | 2017-10-26
US20170306044A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER

#20 | 2017-10-26
US20170306036A1
Chemistry; metallurgy

Bispecific antibodies against CD3ϵ and BCMA

#21 | 2017-10-26
US20170306018A1
Chemistry; metallurgy

Bispecific antibodies against CD3EPSILON and ROR1

#22 | 2017-08-31
US20170247441A1
Chemistry; metallurgy

Anti-ANG2 antibodies and methods of use

#23 | 2017-08-24
US20170240629A1
Chemistry; metallurgy

Bispecific antibodies and methods of use in ophthalmology

#24 | 2017-04-27
US20170115304A1
Physics

METHOD FOR DETECTING MULTISPECIFIC ANTIBODY LIGHT CHAIN MISPAIRING

#25 | 2016-12-29
US20160376352A1
Chemistry; metallurgy

Humanized anti-tau(pS422) antibodies and methods of use

#26 | 2016-03-17
US20160075785A1
Chemistry; metallurgy

Bispecific T cell activating antigen binding molecules

#27 | 2015-11-05
US20150315296A1
Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES

InventorID:

1346038 ⎘